Observational study on retained needle fragments in intravenous drug users
Official title: The Prevalence and Predisposing Factors to Retained Drug Needle Fragments in People Who Inject Drugs: a Protocol for a Cross-sectional Observational Study
Run by Tampere University Hospital · NCT05679284 · Data updated 2026-11-12
This study is trying to find out how common it is for people who use intravenous drugs to have leftover pieces of needles in their bodies and what factors might increase this risk.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 1 site (Tampere) |
| Status | Recruiting |
| Started | May 25, 2023 |
| Main results expected | November 15, 2027 |
| Study ends | November 15, 2028 |
| Registry record updated | June 1, 2023 |
| Trial ID | NCT05679284 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with a history of intravenous drug use who are currently receiving treatment for their substance dependence.
✕Probably not a fit
Patients who have never used intravenous drugs or those who are underage or pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to estimate the prevalence of retained needle fragments in people who use intravenous drugs (PWIDs) and identify associated risk factors. Participants will complete a questionnaire regarding their drug use history and injection practices, followed by targeted low-dose X-ray imaging of their injection sites to detect any retained needle fragments. The study seeks to understand the local tissue complications and potential hazards posed by these fragments, which can lead to serious health issues. The research has received ethical approval and aims to provide valuable insights into a largely unstudied aspect of intravenous drug use.
Why it matters
Potential benefit: If successful, this study could improve understanding of the risks associated with intravenous drug use and inform better clinical practices for managing complications.
How similar studies have gone: While there have been case reports on retained needle fragments, this study represents a novel approach to systematically assess the prevalence and risks associated with this condition.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * History of intravenous drug use * Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre. * Adherence to fill in the questionnaire * Participation to X-ray imaging of injection sites Exclusion Criteria: * No history of intravenous drug use * Does not adhere to fill in the questionnaire or refuses X-ray imaging * Pregnancy * Underage (18 years old)
Where it's running
-
Hatanpää Health Center
Tampere, Finland Recruiting
Study contacts
- Principal investigator: Markku Sumanen, MD-PhD — Tampere University
- Study coordinator: Otso Arponen, Associate Professor, MD
- Email: otso.arponen@tuni.fi
- Phone: +358 50 410 6170
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
magnet-guided removal of metallic soft tissue objects in the emergency department
Researchers are testing whether a strong neodymium magnet can help doctors remove metal objects stuck under the skin in adults.
-
Brain imaging to predict teens' response to cannabis treatment
This project will test whether teens' brain activity during a learning task can predict how well 14–17-year-olds do in a 10-week virtual reward program to reduce cannabis use.
-
Ultrasound check for intramuscular bleeding after needle EMG in people taking DOACs
Ultrasound will be used about 30 minutes after a needle EMG to see if people taking direct oral anticoagulants (DOACs) develop intramuscular hematomas.
-
Phentolamine (OraVerse) to reverse dental numbness in children
This tests whether OraVerse (phentolamine mesylate) can shorten the numbness children aged 5–7 experience after dental local anesthesia.
-
International registry for emergency surgery and trauma
This study is setting up a worldwide registry for emergency surgeries and trauma cases to help doctors track their results and find better ways to treat patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.